OCUGEN INC OCGN 深 滬
等待開盤 09-20 09:30:00 美东时间
1.14
+0.020
+1.79%
華盛通- 最 高1.17
- 今 開1.13
- 成交量 301.91万股
- 最 低 1.12
- 昨 收 1.12
- 總市值 2.92亿
- 52周最高 2.105
- 市盈率 靜 --
- 換手率 1.18%
- 52周最低 0.345
- 委 比 57.58%
- 總股本 2.56亿
- 歷史最高 18.77
- 量 比 0.84
- 振 幅 4.46%
- 歷史最低 0.17
- 每 手 1
- 風險率 0.53%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ocugen’s (OCGN) Stock Surges 195% on Promising Gene Therapy Treatment
Ocugen ($OCGN) is grabbing investors’ attention with its stock climbing 195% in...
09-11 15:14
快讯 | ocugen宣布在Ocu410St基因修饰疗法的Gardian临床试验的高剂量队列中完成Stargardt病患者的注射
Ocugen Announces Completion of Dosing in Subjects With Stargardt Disease in Hig...
08-28 18:30
快讯 | Ocugen公司宣布获得加拿大卫生部的批准，开始进行针对广泛视网膜色素变性症迹象的Ocu400第三期临床试验的修饰基因疗法。
Ocugen, Inc. Announces Health Canada Approval to Initiate Phase 3 Clinical Tria...
08-26 19:02
快讯 | Ocugen公司 - Ocu400仍然按照2026年Bla和Maa批准目标稳步前进。
Ocugen Inc - Ocu400 Remains on Track for 2026 Bla and Maa Approval Targets.
08-26 19:02
Peering Into Ocugen's Recent Short Interest
Ocugen's (NYSE:OCGN) short percent of float has risen 15.83% since its last rep...
08-10 04:15
Buy Rating on Ocugen: Strong Financials and Promising Clinical Progress
Analyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on ...
08-09 19:16
快讯 | Ocugen公司：Ocu400计划于2026年获得目标BLA和MAA批准。
Ocugen Inc: Ocu400 Remains on Track for Targeted Bla and Maa Approval in 2026.
08-05 18:30
Why Goldman Sachs Shares Are Falling
Goldman Sachs shares are trading lower by 2.3% during Thursday's session. Investors are reacting to weak U.S. economic data and concerns over potential Fed rate cuts impacting profitability.
08-02 03:42
Why Ambev (ABEV) Stock Is Rising Following Q2 Earnings
Ambev shares are trading higher by 2.4% Thursday morning. The company reported better-than-expected second-quarter sales results.
08-01 23:34
